🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib, open-label, multi-centre study to determine the safety,...
Status
Completed
Location
Research Site
Start Date
2019-08-05
Trial ID
NCT04087174
Treatments Being Tested
This is a multicenter, prospective, open-label, randomized phase II study t...
Status
Recruiting
Location
Haematologie-Onkologie im Zentrum MVZ GmbH
Start Date
2024-12-04
Trial ID
NCT06607757
Treatments Being Tested
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Status
Recruiting
Location
Ellison Clinic at Saint John's
Start Date
2023-04-17
Trial ID
NCT05768139
This is a multicenter, Phase 1b/2 trial in participants with estrogen recep...
Status
Active Not Recruiting
Location
Dothan Hematology and Oncology
Start Date
2023-01-24
Trial ID
NCT05563220
Treatments Being Tested
DESTINY-Breast 08 will investigate the safety, tolerability, PK and prelimi...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-12-17
Trial ID
NCT04556773
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
This study is designed to investigate the safety and tolerability of a new ...
Status
Completed
Location
Research Site
Start Date
2010-12-01
Trial ID
NCT01226316
We hypothesize that promoting a fasting state will strengthen the anti-canc...
Status
Recruiting
Location
University of Minnesota
Start Date
2026-05-18
Trial ID
NCT07624617
Treatments Being Tested
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combin...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-10-11
Trial ID
NCT03616587
Treatments Being Tested
This phase II trial studies how well vismodegib, focal adhesion kinase (FAK...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-09-28
Trial ID
NCT02523014
Treatments Being Tested